The FDA’s recent “preferred study design” for certain covid “vaccine” trials states: “The control group could receive a saline placebo, to permit documentation of the full adverse-event profile.” https://www.nejm.org/doi/full/10.1056/NEJMsb2506929 Yet FDA guidance also states: “The placebo-controlled trial also allows a distinction between adverse events due to the drug and those […]